The Center for HIV/AIDS Vaccine Immunology (CHAVI) could receive more that $300 million over the next 7 years from the United States National Institute of Allergy and Infectious Diseases. This money is to be used in funding drug research for the development of a vaccine to prevent the spread of Human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS).